Summary
229.86 2.46(1.08%)10/04/2024
IQVIA Holdings Inc (IQV)
IQVIA Holdings Inc (IQV)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
| 1.06 | -2.00 | -7.63 | 10.46 | -3.59 | 17.02 | 53.96 | 445.86 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
| Trading Data | ||
| Close | 229.86 | |
| Open | 230.88 | |
| High | 231.06 | |
| Low | 228.06 | |
| Volume | 482,306 | |
| Change | 2.40 | |
| Change % | 1.06 | |
| Avg Volume (20 Days) | 715,110 | |
| Volume/Avg Volume (20 Days) Ratio | 0.67 | |
| 52 Week Range | 167.42 - 261.73 | |
| Price vs 52 Week High | -12.18% | |
| Price vs 52 Week Low | 37.30% | |
| Range | -0.44 | |
| Gap Up/Down | 0.09 | |
Fundamentals | ||
| Market Capitalization (Mln) | 43,065 | |
| EBIDTA | 2,342,000,128 | |
| PE Ratio | 66.8491 | |
| PEG Ratio | 1.0379 | |
| WallStreet Target Price | 300.22 | |
| Book Value | 30.5020 | |
| Earnings Per Share | 3.9290 | |
| EPS Estimate Current Quarter | 2.1200 | |
| EPS Estimate Next Quarter | 2.3800 | |
| EPS Estimate Current Year | 8.9100 | |
| EPS Estimate Next Year | 10.1400 | |
| Diluted EPS (TTM) | 3.9290 | |
| Revenues | ||
| Profit Marging | 0.0567 | |
| Operating Marging (TTM) | 0.0933 | |
| Return on asset (TTM) | 0.0330 | |
| Return on equity (TTM) | 0.1312 | |
| Revenue TTM | 13,536,000,000 | |
| Revenue per share TTM | 70.7030 | |
| Quarterly Revenue Growth (YOY) | 0.2170 | |
| Quarterly Earnings Growth (YOY) | 1.5770 | |
| Gross Profit (TTM) | 3,859,000,000 | |
| Dividends | ||
| Dividend Share | 0.0000 | |
| Dividend Yield | ||
| Valuations | ||
| Trailing PE | 66.8491 | |
| Forward PE | 26.8097 | |
| Price Sales (TTM) | 0.0000 | |
| Price Book (MRQ) | 8.8595 | |
| Revenue Enterprise Value | 4.6220 | |
| EBITDA Enterprise Value | 23.3530 | |
| Shares | ||
| Shares Outstanding | 191,040,000 | |
| Shares Float | 189,656,375 | |
| Shares Short | 0 | |
| Shares Short (Prior Month) | 0 | |
| Shares Ratio | 0.00 | |
| Short Outstanding (%) | 0.00 | |
| Short Float (%) | 0.00 | |
| Insider (%) | 0.71 | |
| Institutions (%) | 90.64 | |
10/04 12:51 EST - zacks.com
Here's Why You Should Retain IQVIA Holdings Shares Now
While IQV benefits from its market leadership, data-driven innovation and global expansion, it must navigate pricing pressure.
Here's Why You Should Retain IQVIA Holdings Shares Now
While IQV benefits from its market leadership, data-driven innovation and global expansion, it must navigate pricing pressure.
10/04 10:47 EST - zacks.com
Here's Why IQVIA Holdings (IQV) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why IQVIA Holdings (IQV) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
09/19 09:00 EST - businesswire.com
IQVIA AI Solution Receives 2024 Frost & Sullivan Global Customer Value Leadership Award
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced that Frost & Sullivan, a leading independent research and consulting firm, has awarded IQVIA with the 2024 Global Customer Value Leadership Award for excellence in the global artificial intelligence (AI) quality and regulatory solutions space for the healthcare industry. Frost &am.
IQVIA AI Solution Receives 2024 Frost & Sullivan Global Customer Value Leadership Award
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced that Frost & Sullivan, a leading independent research and consulting firm, has awarded IQVIA with the 2024 Global Customer Value Leadership Award for excellence in the global artificial intelligence (AI) quality and regulatory solutions space for the healthcare industry. Frost &am.
09/17 12:35 EST - zacks.com
IQV Gains From Clinical Development Capabilities Amid Low Liquidity
IQVIA's vast database, health-care-specific IT infrastructure and analytics-driven developments enable it to grow in the $300-billion market.
IQV Gains From Clinical Development Capabilities Amid Low Liquidity
IQVIA's vast database, health-care-specific IT infrastructure and analytics-driven developments enable it to grow in the $300-billion market.
09/17 10:46 EST - zacks.com
Why IQVIA Holdings (IQV) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why IQVIA Holdings (IQV) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
09/12 10:55 EST - zacks.com
Why IQVIA Holdings (IQV) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why IQVIA Holdings (IQV) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
09/04 14:23 EST - benzinga.com
Contract Research Giant IQVIA's Data Assets Are Biggest Differentiator, Provides Best Exposure To AI And Data Opportunities: Analyst
RBC Capital Markets initiated coverage on IQVIA Holdings Inc. IQV, noting the company's biggest differentiator is its data assets. The analyst says IQVIA is the largest global contract research organization.
Contract Research Giant IQVIA's Data Assets Are Biggest Differentiator, Provides Best Exposure To AI And Data Opportunities: Analyst
RBC Capital Markets initiated coverage on IQVIA Holdings Inc. IQV, noting the company's biggest differentiator is its data assets. The analyst says IQVIA is the largest global contract research organization.
09/04 09:00 EST - prnewswire.com
Signant Health expands availability of its eClinical solutions by joining IQVIA One Home for Sites initiative
PHILADELPHIA , Sept. 4, 2024 /PRNewswire/ -- Signant Health, the leader in evidence generation for modern clinical trials, announced today it has joined IQVIA, a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, in its One Home for Sites™ initiative.
Signant Health expands availability of its eClinical solutions by joining IQVIA One Home for Sites initiative
PHILADELPHIA , Sept. 4, 2024 /PRNewswire/ -- Signant Health, the leader in evidence generation for modern clinical trials, announced today it has joined IQVIA, a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, in its One Home for Sites™ initiative.
08/21 12:30 EST - zacks.com
IQVIA (IQV) Up 3.4% Since Last Earnings Report: Can It Continue?
IQVIA (IQV) reported earnings 30 days ago. What's next for the stock?
IQVIA (IQV) Up 3.4% Since Last Earnings Report: Can It Continue?
IQVIA (IQV) reported earnings 30 days ago. What's next for the stock?
08/20 17:53 EST - seekingalpha.com
Reiterating Buy On IQVIA After Q2 Earnings
IQVIA Holdings Inc. stock is up following Q2 earnings, following business upsides across its portfolio. Q2 earnings showed strong performance in TAS and R&DS divisions, with a record backlog and increased guidance for FY'24. Implied valuations are corroborated at a $260/share price objective, with potential further technical upside to $283/share if momentum sustains.
Reiterating Buy On IQVIA After Q2 Earnings
IQVIA Holdings Inc. stock is up following Q2 earnings, following business upsides across its portfolio. Q2 earnings showed strong performance in TAS and R&DS divisions, with a record backlog and increased guidance for FY'24. Implied valuations are corroborated at a $260/share price objective, with potential further technical upside to $283/share if momentum sustains.
08/16 11:10 EST - zacks.com
Here's Why You Should Retain IQVIA (IQV) Stock for Now
IQVIA (IQV) rides high on robust segmental performance, boosting the company's top line. However, elevated operating expenses and weak liquidity are a major concern.
Here's Why You Should Retain IQVIA (IQV) Stock for Now
IQVIA (IQV) rides high on robust segmental performance, boosting the company's top line. However, elevated operating expenses and weak liquidity are a major concern.
07/29 10:16 EST - zacks.com
Understanding IQVIA (IQV) Reliance on International Revenue
Examine the evolution of IQVIA's (IQV) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
Understanding IQVIA (IQV) Reliance on International Revenue
Examine the evolution of IQVIA's (IQV) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
07/23 12:41 EST - zacks.com
IQV vs. WAT: Which Stock Should Value Investors Buy Now?
Investors interested in Medical - Instruments stocks are likely familiar with IQVIA Holdings (IQV) and Waters (WAT). But which of these two companies is the best option for those looking for undervalued stocks?
IQV vs. WAT: Which Stock Should Value Investors Buy Now?
Investors interested in Medical - Instruments stocks are likely familiar with IQVIA Holdings (IQV) and Waters (WAT). But which of these two companies is the best option for those looking for undervalued stocks?
07/23 09:51 EST - benzinga.com
These Analysts Boost Their Forecasts On IQVIA After Better-Than-Expected Earnings
IQVIA Holdings Inc IQV posted better-than-expected second-quarter earnings on Monday.
These Analysts Boost Their Forecasts On IQVIA After Better-Than-Expected Earnings
IQVIA Holdings Inc IQV posted better-than-expected second-quarter earnings on Monday.
07/22 19:30 EST - zacks.com
Compared to Estimates, IQVIA (IQV) Q2 Earnings: A Look at Key Metrics
Although the revenue and EPS for IQVIA (IQV) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Compared to Estimates, IQVIA (IQV) Q2 Earnings: A Look at Key Metrics
Although the revenue and EPS for IQVIA (IQV) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
07/22 14:00 EST - investopedia.com
IQVIA Stock Pops After It Beats Q2 Earnings Estimates
IQVIA Holdings (IQV) beat second-quarter earnings expectations and raised its full-year outlook on Monday, sending shares higher.
IQVIA Stock Pops After It Beats Q2 Earnings Estimates
IQVIA Holdings (IQV) beat second-quarter earnings expectations and raised its full-year outlook on Monday, sending shares higher.
07/22 12:25 EST - zacks.com
IQVIA (IQV) Surpasses Earnings & Revenue Estimates in Q2
IQVIA's (IQV) second-quarter 2024 earnings and revenues increase year over year.
IQVIA (IQV) Surpasses Earnings & Revenue Estimates in Q2
IQVIA's (IQV) second-quarter 2024 earnings and revenues increase year over year.
07/22 10:37 EST - benzinga.com
IQVIA 'Is A Solid Investment' With Strong Competitive Positioning, Analyst Says After Better Than Expected Q2 Earnings
IQVIA Holdings Inc IQV reported a second adjusted EPS of $2.64, up from $2.43, beating the consensus of $2.57.
IQVIA 'Is A Solid Investment' With Strong Competitive Positioning, Analyst Says After Better Than Expected Q2 Earnings
IQVIA Holdings Inc IQV reported a second adjusted EPS of $2.64, up from $2.43, beating the consensus of $2.57.
07/22 09:15 EST - zacks.com
IQVIA Holdings (IQV) Q2 Earnings and Revenues Surpass Estimates
IQVIA Holdings (IQV) came out with quarterly earnings of $2.64 per share, beating the Zacks Consensus Estimate of $2.58 per share. This compares to earnings of $2.43 per share a year ago.
IQVIA Holdings (IQV) Q2 Earnings and Revenues Surpass Estimates
IQVIA Holdings (IQV) came out with quarterly earnings of $2.64 per share, beating the Zacks Consensus Estimate of $2.58 per share. This compares to earnings of $2.43 per share a year ago.